
To compare the zzso of zzso a new selective zzso zzso inhibitor zzso with zzso zzso in the zzso treatment of major depressive disorder zzso in zzso 

A zzso decision zzso model with a zzso horizon was adapted to the Austrian setting using Austrian clinical zzso All patients zzso zzso 18 zzso started at the primary successfully treated patient was lower ( currency zzso for care path and were referred to specialist care in the secondary care path in case of insufficient zzso Model zzso included zzso probabilities from head-to-head trial data, literature and expert zzso The main outcome measure was success zzso zzso defined as zzso Depression zzso zzso zzso score zzso zzso and costs of treatment zzso drug costs and medical zzso The analysis was performed from the Austrian zzso and Social Healthcare Insurance System zzso zzso The Human Capital approach was used to estimate the zzso costs of lost zzso 

Treatment with zzso yielded lower expected cost and greater effectiveness compared with zzso The expected success rate was higher for zzso zzso compared to zzso zzso From the zzso perspective, the total expected cost per zzso ( currency zzso compared with zzso ( currency zzso From the zzso perspective, these expected costs were currency zzso and currency zzso zzso zzso analyses on unit costs and probabilities demonstrated the zzso of the zzso From the zzso perspective, zzso remained the dominant treatment option, even at a cost of currency 0 for zzso zzso 

zzso is a cost-effective alternative compared to zzso zzso in the zzso treatment of zzso in zzso 

